Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
11 current organization shown on this profile
Board positions
11 supported by public sources, 0 supplied by the profile owner
Committee roles
2Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Dr. Alegria has over 25 years of experience in advancements of vaccines and therapeutic drugs from R&D through commercialization. She previously served as CEO and Chief Innovation Officer of APIE Therapeutics and held senior roles at Biogen, including Senior Vice President of Global Manufacturing. She currently serves as Executive Consultant and Advisor at The LaSalle Group.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Independent Director

Steris (NYSE: STE)

Jan 1, 2023 – Present

Independence: Independent

Source effective: 2026-06-11 · Observed: 2026-07-28T22:43:03.012+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Independent Director

Steris

2023-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Steris

Open Steris profile →

Independent Director at Steris

2023-01-01 → End not stated

current · source reported

Observed: 2026-09-24

SterisSterisEsther M. Alegria

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

  • Steris

    Independent Director

    Verified public fact

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec ProxyPublic profile sourceSupports Independent Director at Steris (NYSE: STE).Open sourceSource 2 · Sec FilingSTE DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:esther-m-alegria
Record version
public-0

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec proxy · Source published: Jun 11, 2026 · Retrieved: Jul 28, 2026

    Supports 1 claim
    • Professional Role: Independent Director at Steris · Claim reviewed: May 13, 2026

  2. STE DEF 14A director slate

    sec filing · Source published: Jun 12, 2025 · Retrieved: May 13, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 13, 2026
    • Board role: Board role: Director · Claim reviewed: May 13, 2026
    • Committee assignments: Committee assignments: Nominating/Governance, Technology · Claim reviewed: May 13, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 13, 2026
    • Executive company: Executive at The LaSalle Group · Claim reviewed: May 13, 2026
    • Executive title: Executive title: Executive Consultant and Advisor · Claim reviewed: May 13, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 13, 2026

  3. STERIS plc director board source

    sec filing · Source published: Jun 12, 2025 · Retrieved: May 3, 2026

    Supports 3 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of STERIS plc · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of STERIS plc · Claim reviewed: May 3, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 13, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 13, 2026

Board independence · Source reportedIndependent director1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of STERIS plcSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · Source reportedBoard role: Director1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 13, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 13, 2026

Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Nominating/Governance, Technology1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 13, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 13, 2026

Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 13, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 13, 2026

Executive company · Source reportedExecutive at The LaSalle Group1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 13, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 13, 2026

Executive title · Source reportedExecutive title: Executive Consultant and Advisor1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 13, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 13, 2026

Technology background · Source reportedTechnology background: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 13, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 13, 2026

View all sources4 records
  1. https://www.sec.gov/Archives/edgar/data/1757898/000119312526267599/d142920ddef14a.htm

    Sec Proxy · Tier not stated · Reviewed Jul 28, 2026

    Supports: Independent Director at Steris (NYSE: STE)

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 13, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Board independence

  4. https://www.sec.gov/Archives/edgar/data/1757898/000119312526267599/d142920ddef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership